Drug-induced Lichenoid exanthema by a vaccine against COVID-19 (Vaxzevria)
A 66-year-old white female presented with a generalized, erythematous and itchy eruption for 3 days after. She reported having fever on the first day of eruption, complaints of asthenia, and anorexia with no other systemic symptoms. She received her first dose of Vaxzevria (AstraZeneca) against COVI...
Saved in:
Main Authors: | Mathieu Ziraldo (Author), Ivan Theate (Author), Olivier Vanhooteghem (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seborrheic keratosis evolution into squamous cell carcinoma: A truly modified sun-related tumor? A case report and review of the literature
by: Ioana Cimpean, et al.
Published: (2019) -
Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases
by: Josephine Hai, BS, et al.
Published: (2021) -
Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin
by: Catarina Moreira, et al.
Published: (2017) -
Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema
by: Emily Y. Kim, et al.
Published: (2023) -
Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study
by: Thiago Cerqueira-Silva, et al.
Published: (2022)